News | January 02, 2024
Inspira Technologies closes on $3.88 million RDO
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering
US FDA approval based on NEURO-TTRansform Phase III results
Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
Mothers Against Vaping also highlights a recent study of young people at risk of experiencing significant respiratory symptoms after just 30 days of electronic cigarette and other new age gateway products use
Atlas Life Sciences (India) has successfully commenced the commercial production of API - Intermediate at its new plant at Chhatral,
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
There has been no loss or injury to human life
Subscribe To Our Newsletter & Stay Updated
